Tag: g-protein coupled receptors market analysis

  • In-Depth 2024 G-Protein Coupled Receptors Market Analysis: Growth, Share, and Emerging Trends

    In-Depth 2024 G-Protein Coupled Receptors Market Analysis: Growth, Share, and Emerging Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    2024-2033 G-Protein Coupled Receptors Market Growth Rate: What’s the Forecast?

    In recent times, there has been a considerable expansion in the market size of g-protein coupled receptors. The estimated growth is from $2.97 billion in 2023 to $3.18 billion in 2024, with a compound annual growth rate (CAGR) of 7.1%. Factors such as advancements in drug discovery, FDA’s stamp of approval, breakthroughs in genomic research, growth in emerging markets, market consolidation, and an increase in the aging population have contributed to the prior growth period.

    The market size of g-protein coupled receptors is anticipated to experience robust growth in the coming years. The market is projected to expand to $4.09 billion by 2028, with a compound annual growth rate (CAGR) of 6.5%. This expected growth can be linked to factors such as the emergence of personalized medicine, heightened attention towards rare diseases, the application of artificial intelligence in drug discovery, patient-oriented drug development, socio-environmental factors, and growth in the biosimilar market. Upcoming trends in the predicted period involve advancements in biotechnology, elevation in r&d investments, technological innovations, collaborations and partnerships, as well as digital therapeutics.

    Claim Your Free Sample of the Global G-Protein Coupled Receptors Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

    What Drivers Are Accelerating the Growth of the g-protein coupled receptors Market?

    The increasing occurrence of cancer is anticipated to spur the advancement of the G-protein-coupled receptors market. Cancer is a medical condition characterized by the abnormal cells multiplying uncontrollably and spreading through the surrounding tissues. The spread of these cancerous cells can also occur via the lymphatic and vascular systems of the body. GPCRs play a critical role in the progression of cancer by regulating replicative immortality, proliferative signaling, resistance to cell death, evasion of growth inhibitors and initiation of invasion and metastasis. For example, the American Society of Clinical Oncology (ASCO), a non-profit organization based in the USA committed to cancer care predicted in March 2023 that kidney cancer will be diagnosed in 81,800 Americans, with 52,360 males and 29,440 females. In addition, in April 2022, Breast cancer overtook lung cancer to become the most diagnosed cancer globally with approximately 2.3 million women affected in 2021 alone as reported by Breast Cancer Research Foundation, a US-based not-for-profit organization dedicated to clinical and translational research on breast cancer. In the USA, where breast cancer has been the predominant cancer for several years, 281,550 women are expected to be diagnosed in 2021. Hence, the escalating prevalence of cancer is fuelling the growth of the G-protein coupled receptors market.

    What Key Segments Can Be Identified in the G-Protein Coupled Receptors Market?

    1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

    2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding and GTP?S Functional Assays, Internalization Assays, Trafficking Assays

    3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

    What Trends Are On the Rise in the G-Protein Coupled Receptors Market?

    The key trend gaining traction in the G-protein-coupled receptor (GPCR) market is the investment in enhancing GPCR screening and developing antibodies. Major businesses operating in the GPCR sector are concentrated on securing investment for the creation of drugs and treatment technologies linked to diseases driven by GPCR. For instance, in February 2023, UK-based venture capital firm LifeArc Ventures made a $16 million investment in Maxion Therapeutics, a UK-based drug discovery firm, to further antibody development for previously untreated ion channel and GPCR-driven conditions. These funds will foster the development of antibody treatments aimed at ion channels and G-protein-coupled receptors (GPCRs) using the exclusive KnotBody technology. The KnotBody platform aids in the discovery of biologicals against ion channels and GPCRs with the assistance of naturally occurring cysteine-rich mini proteins. In addition, Septerna Inc., a US-based biotechnology firm, announced its establishment and Series A financing of $100 million. This Series A funding will further the development of its emerging pipeline of innovative GPCR-oriented medication programs powered by the Native Complex Platform, encompassing numerous therapeutic areas.

    Order Now for Fast Delivery of Your G-Protein Coupled Receptors Market Report!

    https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

    What Regions Are Steering Growth in the G-Protein Coupled Receptors Sector?

    North America was the largest region in the G-protein coupled receptors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The G-Protein Coupled Receptors Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the g-protein coupled receptors market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The G-Protein Coupled Receptors Market Include

    1. G-Protein Coupled Receptors Market Executive Summary

    2. G-Protein Coupled Receptors Market Segments

    3. G-Protein Coupled Receptors Market Size And Template Market Growth Rate

    4. Key G-Protein Coupled Receptors Market Trends

    5. Major G-Protein Coupled Receptors Market Drivers

    ……

    25. Key Mergers And Acquisitions In The G-Protein Coupled Receptors Market

    26. Top G-Protein Coupled Receptors Companies

    27. G-Protein Coupled Receptors Market Opportunities And Strategies

    28. G-Protein Coupled Receptors Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The G-Protein Coupled Receptors Market 2024

    5 Key Insights On The G-Protein Coupled Receptors Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s G-Protein Coupled Receptors Global Market Report 2024, the G-protein coupled receptors market is expected to show significant growth in the forecast period.

    The G-protein-coupled receptors (GPCR) market has witnessed robust growth in recent years, with significant projections for the future.

    • Historical Growth Factors:
      • Advances in drug discovery.
      • FDA approvals.
      • Genomic discoveries.
      • Emerging markets.
      • Market consolidation.
      • Growing aging population.
    • Future Growth Projections:
      • Expected to reach $3.18 billion in 2024.
      • Compound Annual Growth Rate (CAGR) of 7.1%.
      • Estimated to grow to $4.09 billion by 2028.
      • CAGR of 6.5%.
    • Factors Driving Forecasted Growth:
      • Personalized medicine.
      • Focus on rare diseases.
      • Artificial intelligence in drug discovery.
      • Patient-centric drug development.
      • Environmental and social factors.
      • Biosimilar market growth.

    View More On The G-Protein Coupled Receptors Market Report 2024 – https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

     Cancer Prevalence Fueling Market Expansion

    • The rising prevalence of cancer is a significant driver of growth in the GPCR market.
    • GPCRs control various cancer-related processes, including proliferation, metastasis, and apoptosis resistance.
    • Statistics from organizations like ASCO and the Breast Cancer Research Foundation underline the increasing incidence of cancer.
    • Major companies in the market include Pfizer Inc., Roche Holding AG, and Novartis International AG.

    Lifearc Ventures Backs Maxion Therapeutics And Septerna Inc. To Propel G-Protein-Coupled Receptor Research

    • Investment in GPCR screening and antibody development is a growing trend.
    • LifeArc Ventures’ investment in Maxion Therapeutics and Septerna Inc. demonstrates increasing interest and support for GPCR-related research.
    • Maxion Therapeutics focuses on antibody development for ion channel and GPCR-driven disorders.
    • Septerna Inc. is working on innovative GPCR-targeted medication programs using its Native Complex Platform.

    Eurofins Scientific Strengthens Drug Discovery Arm With Acquisition Of Beacon Discovery

    • Eurofins Scientific’s acquisition of Beacon Discovery in February 2021 expands its drug discovery capabilities.
    • Beacon Discovery specializes in GPCR research, aligning with Eurofins’ strategy to support pharmaceutical industry partners.
    • The acquisition broadens Eurofins’ product portfolio in ADMET, in vitro pharmacology, and chemistry services.

    Market Segmentation and Regional Outlook

    • Market Segments:
      • By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands.
      • By Assay: Various functional assays and binding assays.
      • By Applications: Cancer Research, CNS Research, Metabolic Research, and more.
    • Regional Outlook:
      • North America led the market in 2023.
      • Asia-Pacific expected to witness the fastest growth in the forecast period.

    In conclusion, the G-protein-coupled receptors market is poised for substantial growth driven by factors such as cancer prevalence, increased investment in research and development, and strategic acquisitions. As advancements in biotechnology, digital therapeutics, and collaborative efforts continue, the market is expected to expand further, offering promising opportunities for stakeholders across the pharmaceutical and biotechnology sectors.

    Request A Sample Of The Global G-Protein Coupled Receptors Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=11976&type=smp